CN113980961A - 一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 - Google Patents
一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 Download PDFInfo
- Publication number
- CN113980961A CN113980961A CN202111454170.3A CN202111454170A CN113980961A CN 113980961 A CN113980961 A CN 113980961A CN 202111454170 A CN202111454170 A CN 202111454170A CN 113980961 A CN113980961 A CN 113980961A
- Authority
- CN
- China
- Prior art keywords
- kit
- smn1
- digital pcr
- detecting
- primer probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100021947 Survival motor neuron protein Human genes 0.000 title claims abstract description 25
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 238000001514 detection method Methods 0.000 title claims abstract description 16
- 238000007847 digital PCR Methods 0.000 title claims description 26
- 101150081851 SMN1 gene Proteins 0.000 title description 13
- 101150015954 SMN2 gene Proteins 0.000 title description 11
- 101000617738 Homo sapiens Survival motor neuron protein Proteins 0.000 claims abstract description 35
- 239000000523 sample Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000000018 DNA microarray Methods 0.000 claims description 2
- 238000000137 annealing Methods 0.000 claims description 2
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 238000012257 pre-denaturation Methods 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 18
- 208000002320 spinal muscular atrophy Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000007838 multiplex ligation-dependent probe amplification Methods 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000011304 droplet digital PCR Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000000585 muscular atrophy Diseases 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 208000026072 Motor neurone disease Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000002247 constant time method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 208000005264 motor neuron disease Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组分 | 储存液(μM) | 体积(μL/人份) |
水 | / | 0.15 |
SMNE7-F | 400 | 0.0375 |
SMNE7-R | 400 | 0.0375 |
SMNE8-F | 400 | 0.0375 |
SMNE8-R | 400 | 0.0375 |
GAPDH-F | 400 | 0.0375 |
GAPDH-R | 400 | 0.0375 |
SMN1E7-P | 100 | 0.0375 |
SMN2E7-P | 100 | 0.0375 |
SMN1E8-P | 100 | 0.0375 |
SMN2E8-P | 100 | 0.0375 |
GAPDH-P | 100 | 0.075 |
合计 | / | 0.6 |
试剂 | 体积(μL) | 终浓度 |
水 | 10.4 | |
5×ddPCR Mix | 3 | 1× |
25×SMA | 0.6 | 1× |
DNA | 1 | 10ng<上样量<100ng |
合计 | 15 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111454170.3A CN113980961A (zh) | 2021-12-01 | 2021-12-01 | 一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111454170.3A CN113980961A (zh) | 2021-12-01 | 2021-12-01 | 一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113980961A true CN113980961A (zh) | 2022-01-28 |
Family
ID=79732923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111454170.3A Pending CN113980961A (zh) | 2021-12-01 | 2021-12-01 | 一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113980961A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116144750A (zh) * | 2022-11-10 | 2023-05-23 | 合肥行知生物技术有限公司 | 一种引物探针组、数字pcr试剂盒及应用 |
CN117802223A (zh) * | 2024-03-01 | 2024-04-02 | 北京宏微特斯生物科技有限公司 | 基于2-δδct方法检测smn1基因和smn2基因拷贝数的试剂盒及其使用方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111118151A (zh) * | 2020-03-26 | 2020-05-08 | 广东永诺医疗科技有限公司 | 基于数字pcr法的人smn1与smn2基因拷贝数检测试剂盒 |
-
2021
- 2021-12-01 CN CN202111454170.3A patent/CN113980961A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111118151A (zh) * | 2020-03-26 | 2020-05-08 | 广东永诺医疗科技有限公司 | 基于数字pcr法的人smn1与smn2基因拷贝数检测试剂盒 |
Non-Patent Citations (2)
Title |
---|
DEBORAH L. STABLEY等: "Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR", NEUROGENETICS, vol. 22, pages 56 * |
LINGXIA JIANG等: "Development and validation of a 4‑color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument", SCIENTIFIC REPORTS, vol. 10, no. 1, pages 9 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116144750A (zh) * | 2022-11-10 | 2023-05-23 | 合肥行知生物技术有限公司 | 一种引物探针组、数字pcr试剂盒及应用 |
CN117802223A (zh) * | 2024-03-01 | 2024-04-02 | 北京宏微特斯生物科技有限公司 | 基于2-δδct方法检测smn1基因和smn2基因拷贝数的试剂盒及其使用方法 |
CN117802223B (zh) * | 2024-03-01 | 2024-06-11 | 北京宏微特斯生物科技有限公司 | 基于2-δδct方法检测smn1基因和smn2基因拷贝数的试剂盒及其使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3260555T3 (en) | Hitherto UNKNOWN PROTOCOL FOR PREPARING SEQUENCE LIBRARIES | |
Zhong et al. | Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma | |
KR20170035860A (ko) | 보습 피부 타입 유전자 다형성 마커 및 이의 용도 | |
CN110541025B (zh) | 杜氏肌营养不良基因缺陷的检测方法、引物组合物及试剂盒 | |
KR20100020960A (ko) | 자궁내막증과 연관된 유전자 마커 및 이의 용도 | |
CN111235272B (zh) | 一次性检测肺癌多重基因突变的组合物及其应用 | |
CN113980961A (zh) | 一种用于smn1和smn2基因数字pcr检测的组合物及试剂盒 | |
CN110684838A (zh) | 一种肥厚型心肌病基因检测试剂盒 | |
WO2023179053A1 (zh) | 一种用于靶基因拷贝数检测的方法 | |
CN115948532A (zh) | 基于数字pcr技术的sma检测试剂盒 | |
CN110846408A (zh) | 用于检测ttn基因突变的引物组合及其应用 | |
CN110846409A (zh) | 用于检测tnni3k基因突变的引物组合及其应用 | |
CN114410844A (zh) | 多重qPCR检测GALV和ALB拷贝数判定CAR-T细胞产品中RCR阴阳性的方法 | |
CN110656112B (zh) | 一种Liddle综合征基因检测试剂盒 | |
KR20170051747A (ko) | 피부 주름 발생 민감도 진단용 단일염기다형성 마커 및 이의 용도 | |
WO2020119626A1 (zh) | 一种无创产前检测胎儿是否患有遗传疾病的方法 | |
CN112501306A (zh) | 一种用于CpG岛甲基化表型检测的试剂盒及其应用 | |
US20050074786A1 (en) | Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin D receptor gene | |
CN113166810A (zh) | 包括gba基因单碱基多态性的脑动脉瘤诊断用snp标志物 | |
KR102585879B1 (ko) | 피부 보습 진단용 단일염기다형성 마커 및 이의 용도 | |
CN117802223B (zh) | 基于2-δδct方法检测smn1基因和smn2基因拷贝数的试剂盒及其使用方法 | |
JP2002238577A (ja) | 脳動脈瘤感受性遺伝子 | |
Griffin et al. | Detection of hemizygosity in Hermansky–Pudlak syndrome by quantitative real‐time PCR | |
CN117925806A (zh) | 一种基于CRISPR/Cas13a的ABO血型基因型鉴定方法及所用组合物 | |
US20200181704A1 (en) | Method for determining attention deficit hyperactivity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220613 Address after: 215000 South Building A3, biomedical industrial park, No. 218, Xinghu street, Suzhou Industrial Park, Jiangsu Province Applicant after: SUZHOU BASECARE MEDICAL DEVICE Co.,Ltd. Address before: 250100 No. 27 South Grand Road, Shandong, Ji'nan Applicant before: SHANDONG University |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 215000 unit 101, A3 / F, bio nano Park, 218 Xinghu street, Suzhou Industrial Park, Jiangsu Province Applicant after: SUZHOU BASECARE MEDICAL DEVICE Co.,Ltd. Address before: 215000 South Building A3, biomedical industrial park, No. 218, Xinghu street, Suzhou Industrial Park, Jiangsu Province Applicant before: SUZHOU BASECARE MEDICAL DEVICE Co.,Ltd. |